Androgen Deprivation Therapy [topp]
IMPACT [gngm]
Specific [qlco]
Survival [acty]
Permanent [tmco]
prostate brachytherapy [topp]
Purpose [ftcn]
If [qlco]
Androgen Deprivation Therapy [topp]
IMPACT [gngm]
Specific [qlco]
Biochemical [ftcn]
progression [patf]
free [ftcn]
Survival [acty]
prostate brachytherapy [topp]
Methods [inpr]
Materials [sbst]
Consecutive [qlco]
Patients [podg]
Brachytherapy [topp]
Clinical stage [tmco]
T1b [clas]
T3a [fndg]
AJCC [inpr]
Prostate Cancer [neop]
Patients [podg]
Brachytherapy [topp]
Patients [podg]
Received [qlco]
Androgen Deprivation Therapy [topp]
Duration [tmco]
months [tmco]
months [tmco]
Multiple [qnco]
Clinical Treatment [topp]
Dosimetry [lbpr]
Parameters [fndg]
Evaluated [ftcn]
Specific [qlco]
Biochemical [ftcn]
progression [patf]
free [ftcn]
Survival [acty]
Specific [qlco]
Biochemical [ftcn]
progression [patf]
free [ftcn]
overall survival rate [qnco]
Entire [qnco]
Biochemical [ftcn]
Progression-Free Survival [qnco]
High Risk [qlco]
Patients [podg]
Androgen Deprivation Therapy [topp]
Statistically [ocdi]
IMPACT [gngm]
Survival [acty]
Categories [inpr]
Linear Regression [qnco]
gleason score [clas]
Best [qlco]
Cause Specific Survival [qnco]
Percent [qnco]
biopsies [diap]
Prostate volume [qnco]
Group [idcn]
Predicted [idcn]
Biochemical [ftcn]
Progression-Free Survival [qnco]
Age [orga]
Tobacco use NOS [fndg]
Strong [qlco]
Survival [acty]
Patients [podg]
Died [orgf]
deaths [orgf]
Cardiovascular disease [dsyn]
Second Malignancies [neop]
Date [tmco]
Patients [podg]
Died [orgf]
Metastatic Prostate Cancer [neop]
Conclusions [idcn]
Brachytherapy [topp]
Androgen Deprivation Therapy [topp]
IMPACT [gngm]
Specific [qlco]
Survival [acty]
Group [idcn]
Androgen Deprivation Therapy [topp]
Biochemical [ftcn]
Progression-Free Survival [qnco]
High Risk [qlco]
Patients [podg]
Cardiovascular disease [dsyn]
Second Malignancies [neop]
Prostate Cancer [neop]
